ESSA Pharma Inc (EPIX) — Cash Flow-to-Debt Ratio
ESSA Pharma Inc (EPIX) has a Cash Flow-to-Debt Ratio of -2.63x as of June 2025, meaning its operating cash flow of $-4.20 Million could theoretically repay -3% of its total liabilities ($1.60 Million) in one year. Check EPIX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ESSA Pharma Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for ESSA Pharma Inc across 13 annual periods. Also explore balance sheet size of ESSA Pharma Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for ESSA Pharma Inc (2012–2024)
Year-by-year debt coverage analysis for ESSA Pharma Inc. For market capitalisation and broader financial context, see ESSA Pharma Inc (EPIX) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -6.48x | $-22.72 Million | $3.51 Million | ▼ -14.5% |
| 2023 | -5.66x | $-19.78 Million | $3.50 Million | ▲ +52.9% |
| 2022 | -12.03x | $-28.70 Million | $2.39 Million | ▼ -96.8% |
| 2021 | -6.11x | $-25.42 Million | $4.16 Million | ▲ +52.1% |
| 2020 | -12.76x | $-16.98 Million | $1.33 Million | ▼ -482.6% |
| 2019 | -2.19x | $-12.25 Million | $5.59 Million | ▼ -47.2% |
| 2018 | -1.49x | $-10.22 Million | $6.87 Million | ▲ +15.3% |
| 2017 | -1.76x | $-17.35 Million | $9.88 Million | ▼ -25.6% |
| 2016 | -1.40x | $-15.30 Million | $10.94 Million | ▲ +65.1% |
| 2015 | -4.01x | $-12.30 Million | $3.07 Million | ▼ -329.5% |
| 2014 | -0.93x | $-2.08 Million | $2.23 Million | ▼ -21848.8% |
| 2013 | 0.00x | $-763.35 | $179.34K | ▲ +100.0% |
| 2012 | -13.71x | $-1.82K | $133.04 | — |